Synapse

← Salim Yusuf

Papers by Salim Yusuf

Page 13 · newest first

  1. C-reactive protein is a bystander of cardiovascular diseaseEuropean Heart Journal · 2010
  2. Testing for heterogeneity among the components of a binary composite outcome in a clinical trialBMC Medical Research Methodology · 2010
  3. Efficacy and Safety of Angiotensin Receptor Blockade are Not Modified by Aspirin in Patients with Chronic Heart Failure: A Cohort Study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) ProgrammeEuropean Journal of Heart Failure · 2010
  4. Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin ResistanceDiabetes Care · 2010
  5. Baseline Characteristics and Outcomes of Patients with Heart Failure Receiving Bronchodilators in the CHARM ProgrammeEuropean Journal of Heart Failure · 2010
  6. Cognitive Function and Anticoagulation Control in Patients With Atrial FibrillationCirculation Cardiovascular Quality and Outcomes · 2010
  7. Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or BothCirculation · 2010
  8. Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic StrokeStroke · 2010
  9. Which antithrombotic to use during PCI?European Heart Journal · 2010
  10. Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary SyndromesCirculation · 2010
  11. Rationale and Design of INTERSTROKE: A Global Case-Control Study of Risk Factors for StrokeNeuroepidemiology · 2010
  12. Comprehensive Analysis of Genomic Variation in the LPA Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European CaucasiansCirculation Cardiovascular Genetics · 2009
  13. Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting GlucoseDiabetes Care · 2009
  14. Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial InfarctionCirculation · 2009
  15. Polypill: the evidence and the promiseCurrent Opinion in Lipidology · 2009
  16. Ichthyosis hystrix Curth–Macklin type in an African girlInternational Journal of Dermatology · 2009
  17. Adherence to Medication According to Sex and Age in the CHARM ProgrammeEuropean Journal of Heart Failure · 2009
  18. Meta-Analysis of the INSIG2 Association with Obesity Including 74,345 Individuals: Does Heterogeneity of Estimates Relate to Study Design?PLoS Genetics · 2009
  19. Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control studyHeart · 2009
  20. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromesEuropean Heart Journal · 2009
  21. Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic StrokeStroke · 2009
  22. Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular DiseaseCirculation · 2009
  23. Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2009
  24. Iatrogenic Adverse Events in the Coronary Care UnitCirculation Cardiovascular Quality and Outcomes · 2009
  25. Multi-Ethnic Genetic Association Study of Carotid Intima-Media Thickness Using a Targeted Cardiovascular SNP MicroarrayStroke · 2009
  26. A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemiaHuman Molecular Genetics · 2009
  27. Management of stable anginaBMJ · 2009
  28. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial studyJournal of Hypertension · 2009
  29. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTsClinical Trials · 2009
  30. Prevalence of cardiovascular risk factors in the Middle East: a systematic reviewEuropean Journal of Cardiovascular Prevention & Rehabilitation · 2009
  31. Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China studyHeart · 2009
  32. Early versus Delayed Invasive Intervention in Acute Coronary SyndromesNew England Journal of Medicine · 2009
  33. Replication of genetic associations with plasma lipoprotein traits in a multiethnic sampleJournal of Lipid Research · 2009
  34. Environmental and societal influences acting on cardiovascular risk factors and disease at a population level: a reviewInternational Journal of Epidemiology · 2009
  35. Computerized tomographic finding of saddle pulmonary embolism is associated with high mortality in cancer patientsInternal Medicine Journal · 2009
  36. Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trialsEuropean Heart Journal · 2009
  37. Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blockerTherapeutic Advances in Cardiovascular Disease · 2009
  38. Liver Function Abnormalities and Outcome in Patients with Chronic Heart Failure: Data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) ProgramEuropean Journal of Heart Failure · 2009
  39. Recent Advances and Future Directions in Myocardial InfarctionCardiology · 2008
  40. Microscopic Understanding of Negative Magnetization in Cu, Mn, and Fe Based Prussian Blue AnaloguesPhysical Review Letters · 2008
  41. Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programmeEuropean Heart Journal · 2008
  42. Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic RangeCirculation · 2008
  43. Dietary Patterns and the Risk of Acute Myocardial Infarction in 52 CountriesCirculation · 2008
  44. Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART)Vascular Medicine · 2008
  45. Association of the FABP2 T54 Variant with Plasma Triglycerides and Insulin Resistance in a Multiethnic PopulationClinical Chemistry · 2008
  46. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failureEuropean Heart Journal · 2008
  47. Effect of acute bilateral adrenalectomy and reserpine on gastric mucus secretion and mucosal injury in pyloric ligated ratsAFRICAN JOURNAL OF BIOTECHNOLOGY · 2008
  48. Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent StrokeNew England Journal of Medicine · 2008
  49. Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsNew England Journal of Medicine · 2008
  50. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesEuropean Heart Journal · 2008